Genetic Technologies Ltd. (GENE) Stock News, Earnings & History

(NASDAQ:GENE) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 4.79
52wk low: 2.00
EPS: -0.36
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 40.03M
Avg Vol (3m): 119,833

Latest Headlines

More Articles About GENE →

Company On Twitter

Company Profile

Genetic Technologies Limited is a biotechnology company which does advanced DNA genetic research and testing. The Company has several gene-based patents which include intron sequence analysis, genomic mapping and fetal cell recovery. Genetic also operates a testing laboratory that performs disputed paternity testing by DNA techniques.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for Genetic Technologies Ltd..

Yahoo, HV, Market Watch, The Wall St. Journal